About Innovate Biopharma
Innovate Biopharma is a company based in Raleigh (United States) founded in 2012. Innovate Biopharma has raised $48.58 million across 12 funding rounds. Innovate Biopharma has completed 1 acquisition, including RDD Pharma. Innovate Biopharma offers products and services including INN-202, INN-217, INN-289, and INN-108. Innovate Biopharma operates in a competitive market with competitors including Ironwood Pharma, ImaginAb, RedHill Biopharma, Alcresta and Seed, among others.
- Headquarter Raleigh, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$48.58 M (USD)
in 12 rounds
-
Latest Funding Round
$2.75 M (USD), Debt – Conventional
Jan 17, 2020
-
Investors
Not available
-
Employee Count
Not available
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Innovate Biopharma
Innovate Biopharma offers a comprehensive portfolio of products and services, including INN-202, INN-217, INN-289, and INN-108.
Targets celiac disease treatment in Phase 3 trials.
Addresses nonalcoholic steatohepatitis in early clinical stages.
Focuses on Crohn’s disease subset in Phase 1 trials.
Treats ulcerative colitis and other inflammatory disorders.
Funding Insights of Innovate Biopharma
Innovate Biopharma has successfully raised a total of $48.58M across 12 strategic funding rounds. The most recent funding activity was a Debt – Conventional round of $2.75 million completed in January 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investments & Acquisitions by Innovate Biopharma
Innovate Biopharma has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include RDD Pharma.
Investment portfolio details for Innovate Biopharma
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Developing targeted therapeutics and delivery systems for anorectal and GI disorders
|
Locked | Locked | 2008 | Locked |
Complete acquisition details for Innovate Biopharma
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Innovate Biopharma
Detailed financials for Innovate Biopharma
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Innovate Biopharma Comparisons
Peer comparison for Innovate Biopharma
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Innovate Biopharma
Innovate Biopharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Ironwood Pharma, ImaginAb, RedHill Biopharma, Alcresta and Seed, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Therapeutics for gastrointestinal disorders, including linaclotide, are developed.
|
|
| Locked | Locked | Locked |
ImaginAb is focused on developing advanced immuno-oncology imaging technologies.
|
|
| Locked | Locked | Locked |
Developer of therapeutics for the treatment of gastrointestinal and infectious diseases
|
|
| Locked | Locked | Locked |
Enzyme-based products for gastrointestinal disorders are developed using immobilization technology.
|
|
| Locked | Locked | Locked |
Synbiotics are developed for simulating the gut microbiome.
|
|
| Locked | Locked | Locked |
Therapeutics for gastrointestinal, cardio-renal, and metabolic diseases are developed.
|
Detailed competitors of Innovate Biopharma
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Innovate Biopharma
Complete news archive for Innovate Biopharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Innovate Biopharma
Innovate Biopharma was founded in 2012 and raised its 1st funding round 1 year after it was founded.
Innovate Biopharma is headquartered in Raleigh, United States. It is registered at Raleigh, North Carolina, United States.
Innovate Biopharma is a funded company, having raised a total of $48.58M across 12 funding rounds to date.
Innovate Biopharma was founded in 2012 in Raleigh, United States, as a clinical-stage biopharmaceutical company specializing in gastroenterology. The pipeline features INN-202, a tight junction regulator in phase 3 trials for celiac disease, and INN-108, a small molecule in phase 2 for inflammatory bowel disorders and mild to moderate ulcerative colitis. An imaging agent, INN-329 (secretin), is also advanced in phase 3 trials with MRCP for non-invasive pancreaticobiliary assessment.
Innovate Biopharma's top competitors include Ironwood Pharma, Ardelyx and RedHill Biopharma.
Innovate Biopharma offers INN-202, INN-217, INN-289, and INN-108.
Innovate Biopharma has made 1 acquisition, including RDD Pharma.